Daiken Biomedical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Oct '25 Oct 22, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	10,470	10,860	-	-
Enterprise Value	9,282	10,038	-	-
Last Close Price	174.50	174.20	-	-
PE Ratio	42.46	101.90	-	-
PS Ratio	6.43	7.97	-	-
PB Ratio	9.45	8.31	-	-
P/TBV Ratio	9.50	8.33	-	-
P/FCF Ratio	48.83	215.06	-	-
P/OCF Ratio	48.78	209.86	-	-
EV/Sales Ratio	5.70	7.37	-	-
EV/EBITDA Ratio	39.23	65.55	-	-
EV/EBIT Ratio	40.25	67.41	-	-
EV/FCF Ratio	43.28	198.77	-	-
Debt / Equity Ratio	0.00	0.00	1.12	0.60
Debt / EBITDA Ratio	0.00	0.01	1.35	1.21
Debt / FCF Ratio	0.00	0.05	2.63	3.27
Asset Turnover	0.93	1.19	1.87	-
Inventory Turnover	1.89	1.99	1.71	-
Quick Ratio	2.26	5.36	0.80	1.23
Current Ratio	2.87	6.56	1.64	2.17
Return on Equity (ROE)	20.95%	13.71%	67.55%	-
Return on Assets (ROA)	8.21%	8.15%	20.01%	-
Return on Capital (ROIC)	10.43%	10.15%	28.76%	-
Return on Capital Employed (ROCE)	20.80%	11.40%	68.80%	38.90%
Earnings Yield	2.36%	0.98%	-	-
FCF Yield	2.05%	0.46%	-	-
Dividend Yield	2.31%	2.31%	-	-
Payout Ratio	18.65%	2.89%	87.59%	-
Buyback Yield / Dilution	-139.65%	-95.20%	-44.34%	-
Total Shareholder Return	-137.34%	-92.88%	-44.34%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.